Dr. Jeffrey Neidhart
Claim this profileSan Juan Oncology Associates
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
1 reported clinical trial
3 drugs studied
Affiliated Hospitals
More about Jeffrey Neidhart
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Jeffrey Neidhart has experience with
- Dexamethasone
- Ixazomib
- Lenalidomide
Breakdown of trials Jeffrey Neidhart has run
Multiple Myeloma
Plasma Cell Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Neidhart specialize in?
Jeffrey Neidhart focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Jeffrey Neidhart currently recruiting for clinical trials?
No, Jeffrey Neidhart is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jeffrey Neidhart has studied deeply?
Yes, Jeffrey Neidhart has studied treatments such as Dexamethasone, Ixazomib, Lenalidomide.
What is the best way to schedule an appointment with Jeffrey Neidhart?
Apply for one of the trials that Jeffrey Neidhart is conducting.
What is the office address of Jeffrey Neidhart?
The office of Jeffrey Neidhart is located at: San Juan Oncology Associates, Farmington, New Mexico 87401 United States. This is the address for their practice at the San Juan Oncology Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.